223 related articles for article (PubMed ID: 7682802)
1. Infiltrating lobular breast carcinoma: detection of occult regional lymph node metastasis by immunohistochemistry.
Kainz C; Gitsch G; Lee A; Danihel L; Breitenecker G
Anticancer Res; 1993; 13(1):73-4. PubMed ID: 7682802
[TBL] [Abstract][Full Text] [Related]
2. Detection of occult metastatic lobular carcinoma in axillary lymph nodes using anticytokeratin monoclonal antibodies.
Lachman MF; Ricci A; Pedersen CA; Cartun RW; Strumpf KB
Conn Med; 1992 Feb; 56(2):65-8. PubMed ID: 1373112
[TBL] [Abstract][Full Text] [Related]
3. Occult metastases in axillary lymph nodes as a predictor of survival in node-negative breast carcinoma with long-term follow-up.
Reed W; Bøhler PJ; Sandstad B; Nesland JM
Breast J; 2004; 10(3):174-80. PubMed ID: 15125740
[TBL] [Abstract][Full Text] [Related]
4. Occult metastases in the axillary lymph nodes of patients with breast cancer node negative by clinical and histologic examination and conventional histology.
Chen ZL; Wen DR; Coulson WF; Giuliano AE; Cochran AJ
Dis Markers; 1991; 9(5):239-48. PubMed ID: 1724633
[TBL] [Abstract][Full Text] [Related]
5. Detection of metastatic breast carcinoma with monoclonal antibodies to cytokeratins.
Sedmak DD; Meineke TA; Knechtges DS
Arch Pathol Lab Med; 1989 Jul; 113(7):786-9. PubMed ID: 2472784
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical detection of lymph node metastases in node-negative breast cancer patients.
Kohlberger P; Gantert M; Volk-Orlowska T; Kieback DG; Gitsch G
Anticancer Res; 2001; 21(1B):697-9. PubMed ID: 11299828
[TBL] [Abstract][Full Text] [Related]
7. Validation of axillary sentinel lymph node detection in the staging of early lobular invasive breast carcinoma: a prospective study.
Classe JM; Loussouarn D; Campion L; Fiche M; Curtet C; Dravet F; Pioud R; Rousseau C; Resche I; Sagan C
Cancer; 2004 Mar; 100(5):935-41. PubMed ID: 14983488
[TBL] [Abstract][Full Text] [Related]
8. Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma: a multicenter study.
Weaver DL; Krag DN; Ashikaga T; Harlow SP; O'Connell M
Cancer; 2000 Mar; 88(5):1099-107. PubMed ID: 10699901
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
[TBL] [Abstract][Full Text] [Related]
10. Clinical impact of micrometastasis of the lymph node in gastric cancer.
Ishigami S; Natsugoe S; Tokuda K; Nakajo A; Higashi H; Watanabe T; Aridome K; Hokita S; Aikou T
Am Surg; 2003 Jul; 69(7):573-7. PubMed ID: 12889619
[TBL] [Abstract][Full Text] [Related]
11. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
12. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.
Pendas S; Dauway E; Cox CE; Giuliano R; Ku NN; Schreiber RH; Reintgen DS
Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202
[TBL] [Abstract][Full Text] [Related]
13. [Intraoperative evaluation of axillary lymph nodes for micrometastases using immunohistochemistry--preliminary study].
Sawada T; Sakurada M; Hasegawa Y; Kobayashi M
Rinsho Byori; 2003 Jun; 51(6):522-7. PubMed ID: 12884738
[TBL] [Abstract][Full Text] [Related]
14. The relevance of occult axillary micrometastasis in ductal carcinoma in situ: a clinicopathologic study with long-term follow-up.
Lara JF; Young SM; Velilla RE; Santoro EJ; Templeton SF
Cancer; 2003 Nov; 98(10):2105-13. PubMed ID: 14601079
[TBL] [Abstract][Full Text] [Related]
15. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast.
Broekhuizen LN; Wijsman JH; Peterse JL; Rutgers EJ
Eur J Surg Oncol; 2006 Jun; 32(5):502-6. PubMed ID: 16569492
[TBL] [Abstract][Full Text] [Related]
16. Histological detection of minimal metastatic involvement in axillary sentinel nodes: a rational basis for a sensitive methodology usable in daily practice.
Fréneaux P; Nos C; Vincent-Salomon A; Genin P; Sigal-Zafrani B; Al Ghuzlan A; Birolini MJ; Clough K; Sastre-Garau X
Mod Pathol; 2002 Jun; 15(6):641-6. PubMed ID: 12065778
[TBL] [Abstract][Full Text] [Related]
17. [Detection of micrometastases in axillary lymph nodes of node-negative breast cancer patients and its clinical significance].
Wu J; Yu Z; Li G
Zhonghua Zhong Liu Za Zhi; 1996 Jul; 18(4):289-91. PubMed ID: 9387324
[TBL] [Abstract][Full Text] [Related]
18. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U
J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808
[TBL] [Abstract][Full Text] [Related]
19. Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients.
Viale G; Bosari S; Mazzarol G; Galimberti V; Luini A; Veronesi P; Paganelli G; Bedoni M; Orvieto E
Cancer; 1999 Jun; 85(11):2433-8. PubMed ID: 10357414
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of genetically diagnosed lymph node micrometastasis in non-small cell lung carcinoma cases.
Hashimoto T; Kobayashi Y; Ishikawa Y; Tsuchiya S; Okumura S; Nakagawa K; Tokuchi Y; Hayashi M; Nishida K; Hayashi S; Hayashi J; Tsuchiya E
Cancer Res; 2000 Nov; 60(22):6472-8. PubMed ID: 11103815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
